Moving Target: Why a Cancer 'Cure' Is So Elusive

In the realm of targeted cancer treatment, Carla Leslie is a success story. Leslie was diagnosed in September of 2010 with Stage 3C breast cancer, a disease that kills 50 to 60 percent of those who have it within five years. She was treated at MD Anderson Cancer Center in Houston with chemotherapy plus Herceptin, a drug that targets a specific genetic mutation in certain kinds of breast cancer. The results were remarkable; Leslie is now in remission. "It was unbelievable, it was truly...Full Story
Commenting on this article is closed.